Compare TECX & TWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | TECX | TWN |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | 51 | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 393.0M | 351.0M |
| IPO Year | N/A | 1994 |
| Metric | TECX | TWN |
|---|---|---|
| Price | $29.47 | $64.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $80.40 | N/A |
| AVG Volume (30 Days) | ★ 323.2K | 36.0K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.70 | $26.45 |
| 52 Week High | $35.99 | $67.83 |
| Indicator | TECX | TWN |
|---|---|---|
| Relative Strength Index (RSI) | 54.30 | 53.84 |
| Support Level | $16.83 | $59.82 |
| Resistance Level | $35.99 | $64.25 |
| Average True Range (ATR) | 2.85 | 2.03 |
| MACD | -0.27 | 0.09 |
| Stochastic Oscillator | 55.28 | 43.82 |
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Taiwan Fund Inc is a diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment predominantly in equity securities listed in Taiwan stock exchange and the Republic of China. In selecting the companies for investments fund's portfolio managers will consider overall growth prospects, competitive position in the respective industry technology, research, and development, productivity, profit margins, return on investment, capital resources, government regulation, management and other factors.